iPhone Screenshots
Description
This Immersive Enhanced Reality experience investigates the role of vascular endothelial growth factor (VEGF) in diabetic macular edema (DME), neovascular age-related macular degeneration (nAMD), and retinal vein occlusion (RVO). The program presents management options for retinal disease, optimizing anti-VEGF treatment regimens through dosing strategies and next-generation anti-VEGF therapies to reduce treatment burden, and optimize outcomes in patients with these retinal conditions.